10x Genomics, Inc. - CLASS A COMMON STOCK (TXG)

Historical Holders from Q3 2019 to Q4 2025

Type / Class
Equity / CLASS A COMMON STOCK
Symbol
TXG on Nasdaq
Shares outstanding
117,557,908
Price per share
$16.31
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
123,141,566
Holdings value
$1,439,488,398
% of all portfolios
0%
Share change
+606,349
Value change
+$7,701,066
Average buys %
+0%
Average sells %
-0%
Number of holders
310
Price from insider filings
$1.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 12% $155,176,941 13,274,332 The Vanguard Group 30 Sep 2025
FMR LLC 11% +34% $207,075,905 +$55,657,565 12,696,254 +37% FMR LLC 31 Dec 2025
ARK Investment Management LLC 10% -12% $138,963,659 -$11,202,726 11,887,396 -7.5% ARK Investment Management LLC 30 Sep 2025
BlackRock, Inc. 7.6% $80,633,076 8,496,636 BlackRock, Inc. 30 Jun 2025
Sumitomo Mitsui Trust Group, Inc. 4.7% -14% $62,906,450 -$7,397,081 5,381,219 -11% Sumitomo Mitsui Trust Group, Inc. 30 Sep 2025
Amova Asset Management Americas, Inc. 4.7% -14% $62,855,762 -$7,397,081 5,376,883 -11% Amova Asset Management Americas, Inc. 30 Sep 2025
MILLENNIUM MANAGEMENT LLC 2.7% -48% $35,444,747 -$28,634,549 3,060,859 -45% Millennium Management LLC 30 Jun 2025
As of 30 Sep 2025, 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) has 310 institutional shareholders filing 13F forms. They hold 123,141,566 shares .

Top 25 institutional shareholders own 83% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 11% 13,274,332 +6.7% 0% $155,176,941
ARK Investment Management LLC 10% 11,887,396 -14% 0.83% $138,963,656
BlackRock, Inc. 8% 9,460,109 +0.27% 0% $110,588,675
FMR LLC 7.2% 8,458,001 -6% 0.01% $98,874,027
MILLENNIUM MANAGEMENT LLC 4.6% 5,437,969 +89% 0.05% $63,569,858
Sumitomo Mitsui Trust Group, Inc. 4.6% 5,381,219 -11% 0.04% $62,906,450
Amova Asset Management Americas, Inc. 4.6% 5,376,883 -11% 0.61% $62,855,762
WELLINGTON MANAGEMENT GROUP LLP 3.6% 4,285,628 +127% 0.01% $50,098,990
Quantinno Capital Management LP 3% 3,492,459 +56% 0.11% $40,826,846
BANK OF AMERICA CORP /DE/ 2.9% 3,413,286 +13% 0% $39,901,312
JACOBS LEVY EQUITY MANAGEMENT, INC 2.5% 2,947,989 +23% 0.14% $34,461,991
MORGAN STANLEY 2.4% 2,817,242 -19% 0% $32,933,566
AQR CAPITAL MANAGEMENT LLC 2.3% 2,726,992 -34% 0.02% $31,469,488
GEODE CAPITAL MANAGEMENT, LLC 2.3% 2,711,243 +2.3% 0% $31,699,106
GOLDMAN SACHS GROUP INC 2.3% 2,675,327 +340% 0% $31,274,573
STATE STREET CORP 2.1% 2,520,199 +1.1% 0% $29,461,126
Capital World Investors 1.2% 1,452,300 0% 0% $16,977,387
ROYAL BANK OF CANADA 1.2% 1,429,725 +594% 0% $16,714,000
T. Rowe Price Investment Management, Inc. 1.1% 1,342,423 +37% 0.01% $15,693,000
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1.1% 1,321,256 -13% 0.05% $15,445,483
TWO SIGMA ADVISERS, LP 1% 1,199,900 -34% 0.03% $14,026,831
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.97% 1,145,188 +27% 0% $13,387,248
JPMORGAN CHASE & CO 0.91% 1,073,865 +778% 0% $12,553,483
RENAISSANCE TECHNOLOGIES LLC 0.89% 1,044,921 -29% 0.02% $12,215,126
NORTHERN TRUST CORP 0.88% 1,039,263 +3% 0% $12,148,983

Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 264,327 $4,667,252 +$665,176 $16.31 10
2025 Q3 123,141,566 $1,439,488,398 +$7,701,066 $11.69 310
2025 Q2 122,631,794 $1,420,549,489 +$119,573,101 $11.58 293
2025 Q1 113,812,509 $993,370,355 +$50,873,978 $8.73 268
2024 Q4 104,495,233 $1,500,590,992 -$41,529,684 $14.36 270
2024 Q3 104,304,360 $2,354,431,257 -$4,309,672 $22.58 257
2024 Q2 105,360,936 $2,049,048,097 +$26,354,694 $19.45 253
2024 Q1 102,011,809 $3,828,369,246 +$142,555,855 $37.53 279
2023 Q4 116,605 $6,525,215 -$825,186 $55.96 4
2023 Q3 89,524,965 $3,692,823,135 +$73,603,614 $41.25 249
2023 Q2 82,823,718 $4,625,444,201 +$183,094,897 $55.84 263
2023 Q1 90,125,424 $5,023,924,896 +$210,067,104 $55.79 252
2022 Q4 86,176,546 $3,140,500,591 +$101,949,071 $36.44 247
2022 Q3 85,199,420 $2,425,008,359 -$45,855,888 $28.48 198
2022 Q2 85,867,593 $3,899,520,157 +$76,646,930 $45.25 221
2022 Q1 81,695,058 $6,212,067,203 -$97,605,748 $76.07 278
2021 Q4 77,915,037 $11,586,021,980 -$1,594,607 $148.96 335
2021 Q3 78,757,060 $11,461,535,697 +$122,756,473 $145.58 315
2021 Q2 77,509,086 $15,172,109,886 +$1,477,415,632 $195.82 331
2021 Q1 68,807,330 $12,451,695,026 +$737,380,948 $181.00 309
2020 Q4 66,221,941 $9,376,536,370 -$748,426,364 $141.60 293
2020 Q3 68,904,562 $8,522,631,879 +$1,082,862,489 $124.68 214
2020 Q2 60,818,029 $5,431,976,110 +$1,146,244,481 $89.31 138
2020 Q1 38,852,958 $2,421,421,019 +$608,374,452 $62.32 99
2019 Q4 30,792,033 $2,347,887,329 +$108,528,168 $76.25 84
2019 Q3 22,339,937 $1,125,942,955 +$1,125,943,318 $50.40 92